Avanza Fonder AB Makes New $3.68 Million Investment in Keurig Dr Pepper Inc. (NASDAQ:KDP)

Avanza Fonder AB purchased a new stake in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 114,439 shares of the company's stock, valued at approximately $3,676,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. American Century Companies Inc. increased its stake in Keurig Dr Pepper by 3.0% in the second quarter. American Century Companies Inc. now owns 101,670 shares of the company's stock valued at $3,396,000 after purchasing an additional 2,958 shares in the last quarter. Federated Hermes Inc. increased its position in shares of Keurig Dr Pepper by 21.8% in the 2nd quarter. Federated Hermes Inc. now owns 1,757 shares of the company's stock valued at $59,000 after buying an additional 314 shares in the last quarter. Wealth Alliance raised its stake in Keurig Dr Pepper by 49.9% during the 2nd quarter. Wealth Alliance now owns 10,536 shares of the company's stock worth $352,000 after buying an additional 3,505 shares during the period. Meiji Yasuda Asset Management Co Ltd. lifted its holdings in Keurig Dr Pepper by 76.0% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 41,724 shares of the company's stock worth $1,394,000 after acquiring an additional 18,020 shares in the last quarter. Finally, Amalgamated Bank grew its stake in Keurig Dr Pepper by 1.3% in the second quarter. Amalgamated Bank now owns 210,882 shares of the company's stock valued at $7,043,000 after acquiring an additional 2,644 shares during the period. 93.99% of the stock is currently owned by institutional investors.

Keurig Dr Pepper Trading Up 1.1 %

NASDAQ:KDP traded up $0.34 on Friday, reaching $31.62. 6,930,293 shares of the stock traded hands, compared to its average volume of 7,931,290. The company has a current ratio of 0.53, a quick ratio of 0.36 and a debt-to-equity ratio of 0.50. Keurig Dr Pepper Inc. has a 1-year low of $28.61 and a 1-year high of $38.28. The company's 50 day moving average is $32.28 and its 200-day moving average is $34.18. The firm has a market capitalization of $42.89 billion, a price-to-earnings ratio of 19.16, a price-to-earnings-growth ratio of 2.20 and a beta of 0.62.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The company reported $0.51 EPS for the quarter, hitting analysts' consensus estimates of $0.51. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The firm had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same period in the previous year, the company posted $0.48 EPS. The company's revenue for the quarter was up 2.3% on a year-over-year basis. Equities research analysts anticipate that Keurig Dr Pepper Inc. will post 1.92 EPS for the current fiscal year.

Keurig Dr Pepper Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 17th. Investors of record on Friday, January 3rd were given a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date was Friday, January 3rd. Keurig Dr Pepper's payout ratio is currently 55.76%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on KDP shares. Wells Fargo & Company cut their price objective on Keurig Dr Pepper from $42.00 to $40.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. Barclays cut their price objective on shares of Keurig Dr Pepper from $39.00 to $36.00 and set an "overweight" rating on the stock in a research report on Friday. Piper Sandler initiated coverage on Keurig Dr Pepper in a report on Tuesday, January 7th. They set a "neutral" rating and a $35.00 target price for the company. Citigroup cut their price target on Keurig Dr Pepper from $43.00 to $40.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Finally, Jefferies Financial Group decreased their price objective on Keurig Dr Pepper from $42.00 to $41.00 and set a "buy" rating for the company in a report on Friday, October 25th. Six equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat.com, Keurig Dr Pepper presently has a consensus rating of "Moderate Buy" and an average target price of $37.50.

Insider Buying and Selling

In related news, major shareholder Bevco B.V. Jab sold 69,000,000 shares of the business's stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $32.65, for a total value of $2,252,850,000.00. Following the transaction, the insider now directly owns 214,443,879 shares of the company's stock, valued at approximately $7,001,592,649.35. The trade was a 24.34 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.00% of the stock is owned by corporate insiders.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.